Changes in the Pacemaker Rate After Transition From Edwards SAPIEN XT to€SAPIEN 3 Transcatheter Aortic Valve€Implantation
نویسنده
چکیده
METHODS The first 206 patients treated with the S3 were compared with 371 preceding patients treated with SAPIEN XT valves. Patients who previously underwent pacemaker or implantable cardioverter defibrillator implantation or transapical and valve-in-valve procedureswere excluded from the analysis. All patientsweremonitored for at least 7 days. Previous and new conduction abnormalities were documented, and prosthesis implantation height was assessed for the S3.
منابع مشابه
Transcatheter Heart Valve Selection and Permanent Pacemaker Implantation in Patients With Pre‐Existent Right Bundle Branch Block
BACKGROUND Right bundle branch block is an established predictor for new conduction disturbances and need for a permanent pacemaker (PPM) after transcatheter aortic valve replacement. The aim of the study was to evaluate the absolute rates of transcatheter aortic valve replacement related PPM implantations in patients with pre-existent right bundle branch block and categorize for different tran...
متن کاملProspective analysis of 30-day safety and performance of transfemoral transcatheter aortic valve implantation with Edwards SAPIEN XT versus SAPIEN prostheses.
BACKGROUND A new generation of balloon-expandable valves (e.g. Edwards SAPIEN XT) enables the use of a decreased sheath size using the NovaFlex™ delivery system for transfemoral transcatheter aortic valve implantation (TAVI). However, there are few data analysing the efficacy and safety of this new prosthesis. AIMS To evaluate periprocedural and 30-day clinical outcomes using the Edwards SAPI...
متن کاملComparison between the SAPIEN S3 and the SAPIEN XT transcatheter heart valves: A single-center experience
AIM To investigate the clinical outcomes of transcatheter aortic valve implantation (TAVI) with the SAPIEN 3 transcatheter heart valve (S3-THV) vs the SAPIEN XT valve (XT-THV). METHODS We retrospectively analyzed 507 patients that underwent TAVI with the XT-THV and 283 patients that received the S3-THV at our institution between March 2010 and December 2015. RESULTS Thirty-day mortality (3....
متن کاملProcedural Results and Clinical Outcomes of Transcatheter Aortic Valve Implantation in Switzerland: An Observational Cohort Study of Sapien 3 Versus Sapien XT Transcatheter Heart Valves.
BACKGROUND New generation transcatheter heart valves (THV) may improve clinical outcomes of transcatheter aortic valve implantation. METHODS AND RESULTS In a nationwide, prospective, multicenter cohort study (Swiss Transcatheter Aortic Valve Implantation Registry, NCT01368250), outcomes of consecutive transfemoral transcatheter aortic valve implantation patients treated with the Sapien 3 THV ...
متن کاملThe SAPIEN-XT and SAPIEN-3 Valves: How to Implant and Obtain the Best Outcomes.
T ranscatheter aortic valve implantation (TAVI) has become the treatment of choice for symptomatic severe aortic stenosis (AS) in “inoperable” patients and is non-inferior to surgical aortic valve replacement (sAVR) in “high-risk” operable patients.1-4 Since the first-in-human (FIΜ) TAVI in 2002 with the Cribier-Edwards valve, the procedure continues to be refined, with technological improvemen...
متن کامل